MedPath

The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

Early Phase 1
Terminated
Conditions
Infertility
Interventions
Dietary Supplement: dehydroepiandrosterone
Registration Number
NCT01129830
Lead Sponsor
Virginia Center for Reproductive Medicine
Brief Summary

This prospective study evaluates the effect of DHEA supplementation on markers of ovarian reserve in women with diminished ovarian reserve.

Detailed Description

Ovarian reserve markers, such as FSH, estradiol, AMH, ovarian volume and antral follicle counts will be monitored on DHEA supplementation in a prospective fashion.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • infertile women with diminished ovarian reserve
Exclusion Criteria
  • women > 45

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dehydroepiandrosteronedehydroepiandrosteroneinfertile women with low anti mullerian hormone levels
Primary Outcome Measures
NameTimeMethod
live birth rate3 years

Live birth rate will be monitored for women who took DHEA supplementation

Secondary Outcome Measures
NameTimeMethod
number of oocytes3 years

Number of retrieved oocytes for patients undergoing IVF will be monitored along with ovarian response

Trial Locations

Locations (1)

Virginia Center for Reproductive Medicine

🇺🇸

Reston, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath